| |
Standardized Difference Prior to Match
|
Standardized Difference Post Match
|
|---|
|
N
|
(2,518 BMS, 19,101 DES)
|
(2,063 BMS, 2,063 DES)
|
|---|
|
Age (years)
|
-8.3
|
1.9
|
|
Male Sex (%)
|
-1.7
|
-6.2
|
|
Race/Ethnicity
|
-11.3
|
-5.8
|
|
Comorbidities (%)
| | |
|
Diabetes
|
9.1
|
3.5
|
|
Hypertension
|
7.5
|
-3.2
|
|
Prior MI
|
2.7
|
4.7
|
|
PCI Indication:
|
-21.6
|
0.2
|
|
Prior PCI
|
6.1
|
6.1
|
|
Prior CABG
|
2.5
|
2.5
|
|
Congestive Heart Failure
|
3.8
|
3.8
|
|
Prior Stroke
|
0.0
|
0.0
|
|
Peripheral Arterial Disease
|
1.9
|
1.9
|
|
Glomerular Filtration Rate
|
0.3
|
0.3
|
|
Systemic Malignancy
|
-13.4
|
0.4
|
|
Prior Gastrointestinal Bleeding
|
-4.2
|
-0.6
|
|
Chronic Lung Disease
|
-0.3
|
7.8
|
|
Medications
| | |
|
β-Blockers
|
11.9
|
-1.1
|
|
Clopidogrel
|
8.9
|
3.4
|
|
Statin
|
12.3
|
5.3
|
|
ACE-I/ARB
|
9.2
|
4.1
|
|
Warfarin
|
1.0
|
3.1
|
- Abbreviations: MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft surgery.
